Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Aclaris Therapts Cmn

TRADE

NASDAQ: ACRSHealthcare / Biotechnology / USA
19.39-0.53-2.66%Vol 599 1151Y Perf -25.50%
Jun 22nd, 2018 16:00
BID18.96 ASK21.50
Open19.96 Previous Close19.92
Pre-Market- After-Trading19.39
 - -%  - -%
Target Price
47.00 
Analyst Rating
Strong Buy 1.00
Potencial %
142.39 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
11/11/20 
Value Ranking
 —    -
Insiders Value % 3/6/12M
43/43/85 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
52/52/84 
Income Ranking
 —    -
Market Cap (mil)599 
Earnings Rating
Neutral
Price Range Ratio 52wk %
24.02 
Earnings Date
14th Aug 2018

Today's Price Range

19.3520.05

 

52wk Range

16.0130.08

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
1.47%
3 Months
9.80%
6 Months
-15.07%
1 Year
-25.50%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACRS19.39-0.5300-2.66
AAPL184.92-0.5400-0.29
GOOG1 155.48-2.1800-0.19
MSFT100.41-0.7300-0.72
XOM81.381.69002.12
WFC53.94-0.4300-0.79
JNJ122.841.39001.14
FB201.740.24000.12
GE13.050.29002.27
JPM105.75-1.7600-1.64
...

TickerPriceChg.%52 Week High
KMX80.1912.8681.67
MRO21.487.8322.12
APC74.116.6974.72
PCG42.925.9071.57
PDCO24.625.7648.29
NFX30.755.2035.20
DVN43.285.1845.16
FTI32.345.1435.00
HES64.574.6365.89
PXD185.654.29213.40
XEC97.694.18130.16
COP67.784.1071.71
SWN5.473.806.72
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 13.60
Current Ratio 13.90
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin22.40
EBIT Margin-3 228.90
EBITDA Margin-3 208.40
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.07
PS Ratios 219.91
Price to Cash Flow -
Price to Free Cash Flow -8.20
Cash Flow Per Share -2.18
Price to Tangible Book3.53
Book Value per Share6.49
Enterprise Value (in ths.)429 122
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-33.62
ROE last 12 Months -44.66
Return on Assets (5Y Avg) -16.47
ROA last 12 Months -41.74
Return on Capital (5Y Avg) -
ROC last 12 Months -47.75
Return on invested Capital Q -14.19
Return on invested Capital Y-34.69
Assets Turnover0.00
Receivables Turnover10.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 801
Revenue per Share 0.09
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.99-0.981.01
Q04 2017-0.90-0.8011.11
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Q01 2017-0.54-0.4811.11
Q04 2016-0.59-0.4916.95
Q03 2016-0.68-0.5026.47
Q02 2016-0.61-0.62-1.64
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.9578.26Positive
9/2018 QR-1.1160.22Positive
12/2018 FY-4.36--
12/2019 FY-3.39--
Next Report Date14th Aug 2018
Estimated EPS Next Report-0.95
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume599 115
Shares Outstanding (in ths.)30 910
Trades Count1 258
Dollar Volume10 376 781
Avg. Volume281 067
Avg. Weekly Volume189 858
Avg. Monthly Volume266 020
Avg. Quarterly Volume236 126

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

38%62%

Bearish Bullish

66%34%

Bearish Bullish

62%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x